Literature DB >> 16537091

Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix.

Luis Otavio Sarian1, Sophie Françoise Derchain, Adriana Yoshida, José Vassallo, Francisco Pignataro, Liliana Aparecida Lucci De Angelo Andrade.   

Abstract

OBJECTIVES: To assess the expression of cyclooxygenase (COX-2) and Ki67 in cervical squamous lesions in relation to disease severity and human papillomavirus (HPV) detection. SUBJECTS AND METHODS: For this cross-sectional study, 223 women subjected to diathermic conization of the cervix have been enrolled, between February 2001 and April 2004. All patients undertook pelvic examination, including colposcopy and collection of samples for Hybrid Capture II (HCII). Pathological assessment disclosed: 9 cases of normal epithelium/cervicitis, 33 CIN1, 28 CIN2, 146 CIN3 and 7 invasive squamous cell carcinomas. COX-2 and Ki67 protein expression was determined with immunohistochemistry. COX-2 immunoreactivity grading was based on the German ImmonoReactive score. The continuum percentage of positive cells was used for the assessment of nuclear Ki67 expression.
RESULTS: Expression of COX-2 did not correlate with disease severity and with Ki67 expression. The HPV detection rates did not differ significantly across COX-2 protein expression strata, ranging from negative to strong expression. Ki67 expression, however, was higher in the CIN3 group (P = 0.001) as compared to the specimens rendered as normal/cervicitis.
CONCLUSIONS: COX-2 protein expression did not correlate with disease severity or Ki67 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537091     DOI: 10.1016/j.ygyno.2006.01.052

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

2.  Cervical intraepithelial neoplasia in pregnancy: Interference of pregnancy status with p16 and Ki-67 protein expression.

Authors:  Andrea Ciavattini; Francesco Sopracordevole; Jacopo Di Giuseppe; Lorenzo Moriconi; Guendalina Lucarini; Francesca Mancioli; Antonio Zizzi; Gaia Goteri
Journal:  Oncol Lett       Date:  2016-11-29       Impact factor: 2.967

3.  Using biomarkers as objective standards in the diagnosis of cervical biopsies.

Authors:  Mary T Galgano; Philip E Castle; Kristen A Atkins; William K Brix; Sarah R Nassau; Mark H Stoler
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

4.  Spontaneous expression of the gene of KI67 and P53 in cynomolgus monkeys infected with papillomavirus.

Authors:  Huda S Darusman; Sela S Mariya; Isti K Sari; Maulida A Nisa; Kartika Sari; Silmi Mariya; Apon Zaenal Mustopa; Uus Saepuloh
Journal:  Vet World       Date:  2022-04-17

5.  GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling.

Authors:  S Parida; I Pal; A Parekh; B Thakur; R Bharti; S Das; M Mandal
Journal:  Cell Death Dis       Date:  2016-03-24       Impact factor: 8.469

6.  Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer.

Authors:  Jingxin Zhang; Qiqi Liu; Lili Qiao; Pingping Hu; Guodong Deng; Ning Liang; Jian Xie; Hui Luo; Jiandong Zhang
Journal:  Onco Targets Ther       Date:  2017-04-20       Impact factor: 4.147

7.  Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells.

Authors:  Nanyan Jiang; Zhiqiang Tian; Jun Tang; Rongying Ou; Yunsheng Xu
Journal:  Mediators Inflamm       Date:  2015-07-15       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.